350
Views
2
CrossRef citations to date
0
Altmetric
Short Communications

Trends in adverse events and related health-care facility utilization from cough and cold medication exposures in children

, , , , , , , , & show all
Pages 351-354 | Received 18 Jun 2020, Accepted 22 Aug 2020, Published online: 11 Sep 2020

References

  • Lovegrove M, Weidle N, Budnitz D. Trends in emergency department visits for unsupervised pediatric medication exposures, 2004-2013. Pediatrics. 2015;136(4):e821-9–e829.
  • Hampton L, Nguyen D, Edwards J, et al. Cough and cold medication adverse events after market withdrawal and labeling revision. Pediatrics. 2013;132(6):1047–1054.
  • Mazer-Amirshahi M, Reid N, van den Anker J, et al. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers. J Pediatr. 2013;163(5):1372–1376.
  • Green J, Wang G, Reynolds K, et al. Safety profile of cough and cold medication use in pediatrics. Pediatrics. 2017;139(6):e20163070.
  • Green J, Reynolds K, Banner W, et al. Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children. BMC Med Res Methodol. 2018;18(1):175.
  • Guideline on detection and management of duplicate individual cases and Individual Case Safety Reports (ICSRs). London, UK: European Medicines Agency; 2009.
  • Paul I, Yoder K, Crowell K, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004;114(1):e85-90.
  • Horton D, Gerhard T, Strom B. Trends in cough and cold medicine recommendations for children in the United States, 2002-2015. JAMA Pediatr. 2019;173(9):885.
  • Lovegrove M, Hon S, Geller R, et al. Efficacy of flow restrictors in limiting access of liquid medications by young children. J Pediatr. 2013;163(4):1134–1139 e1.
  • Brass E, Reynolds K, Burnham R, et al. Frequency of poison center exposures for pediatric accidental unsupervised ingestions of acetaminophen after the introduction of flow restrictors. J Pediatr. 2018;198:254–259.e1.
  • Restricted delivery systems: flow restrictors for oral liquid drug products. Guidance for industry. Silver Spring, MD: U.S. Department of Health and Human Services Food and Drug Administration; 2020.
  • Heldenbrand S, Martin B, Gubbins P, et al. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc. 2016;56(3):293–302.
  • Brass E, Reynolds K, Burnham R, et al. Medication errors with pediatric liquid acetaminophen after standardization of concentration and packaging improvements. Acad Pediatr. 2018;18(5):563–568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.